首页> 外文OA文献 >Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

【2h】

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

机译：含有增效比例干扰素α-2b和γ（HeberPAG®）的新型制剂在真菌病真菌病患者中的药代动力学和药效学表征：一项开放标签试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yanelda García-Vega; Idrian García-García; Sonia E Collazo-Caballero; Egla E Santely-Pravia; Alieski Cruz-Ramírez; Ángela D Tuero-Iglesias; Cristian Alfonso-Alvarado; Mileidys Cabrera-Placeres; Nailet Castro-Basart; Yaquelín Duncan-Roberts; Tania I Carballo-Treto; Josanne Soto-Matos; Yoandy Izquierdo-Toledo; Dania Vázquez-Blomquist; Elizeth García-Iglesias; Iraldo Bello-Rivero;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon alpha-2b in patients with resected high-risk melanoma. [J] . Daud AI, Xu C, Hwu WJ, Cancer chemotherapy and pharmacology. . 2011,第3期

机译：辅助性聚乙二醇化干扰素α-2b在高危黑色素瘤切除患者中的药代动力学/药效学分析。
2. Phase 1, single-arm, open-label, dose escalation trial of microneedle array-doxorubicin in patients with mycosis fungoides [J] . Akilov O. E., McCann S., Chao E. D., The Journal of investigative dermatology. . 2018,第5a19期

机译：霉菌诱导患者微针阵列 - 多柔比星的第1阶段，单臂，开放标签，剂量升级试验
3. Phase 1, single-arm, open-label, dose escalation trial of microneedle array-doxorubicin in patients with mycosis fungoides [J] . Akilov Oleg, McCann Sue, Erdos Geza, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：霉菌菌诱导患者微针阵列 - 多柔比蛋白的第1阶段，单臂，开放标签，剂量升级试验
4. Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial [O] . Yanelda García-Vega, Idrian García-García, Sonia E Collazo-Caballero, 2012

机译：含有增效比例干扰素α-2b和γ（HeberPAG®）的新型制剂在真菌病真菌病患者中的药代动力学和药效学表征：一项开放标签试验
5. Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers [O] . Idrian García-García, null null, Ignacio Hernández-González, 2016

机译：含有共同配制的干扰素α-2b和γ的新型制剂在健康男性志愿者中的药代动力学和药效学表征

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

著录项

相似文献

相关主题

期刊订阅